Smith+Nephew (NYSE:SNN) is eliminating jobs in Tennessee, the device developer said in response to an inquiry from MassDevice today. “Smith+Nephew is working to transform to a more efficient, effective and agile business,” a spokesperson said by email. “As we make improvements to our business efficiency in Memphis we have identified some activities that are no longer […]
About Jim Hammerand
FDA clears Nonin’s Tru02 over-the-counter fingertip pulse oximeter
Nonin Medical has won FDA 510(k) clearance for its first over-the-counter fingertip pulse oximeter, the TruO2 OTC. The device will be available for purchase on Amazon.com this month, followed by availability through other online retailers. The FDA has warned that pulse oximeters — which beam red and infrared light into a patient’s tissue to measure […]
AdvaMed weighs in on Dr. Oz’s selection to lead CMS
President-elect Donald Trump today said he is nominating Dr. Mehmet Oz to serve as administrator of the Centers for Medicare & Medicaid Services (CMS). Oz would serve under Robert F Kennedy Jr. — who Trump nominated as secretary of the U.S. Department of Health and Human Services — if Oz and Kennedy are confirmed by […]
Trump taps RFK Jr. to run HHS — but two groups could block him
President-elect Donald Trump says he wants Robert F. Kennedy Jr. to serve as secretary of the U.S. Department of Health and Human Services (HHS), giving him oversight of the FDA, CMS, CDC, NIH and other critical health agencies and functions. It’s not clear yet whether Republicans in the U.S. Senate would confirm Kennedy’s appointment given […]
FDA Commissioner Dr. Robert Califf weighs in on Trump’s election as he plans his own exit: ‘Stand by the people’
FDA Commissioner Dr. Robert Califf said industry support will be the biggest factor in keeping talented employees at his agency under President-elect Donald Trump’s administration. In an interview today at the Friends of Cancer Research annual meeting, Califf said he was personally disappointed by the election results but wouldn’t engage in hypotheticals about potential changes […]
Boston Scientific resumes study of pulse field ablation as first-line AFib therapy
Boston Scientific (NYSE: BSX) is resuming its “Avant Guard” study of pulse field ablation as a first-line therapy for persistent atrial fibrillation (AFib). The device developer paused the trial last month, with CEO Mike Mahoney citing the need to “assess a few unanticipated observations.” Boston Scientific said it did not halt the trial due to […]
Solventum raises guidance again after beating The Street in Q3
Solventum (NYSE:SOLV) reported third-quarter results that came in ahead of the consensus forecast on Wall Street. However, shares of SOLV were down 3% to $72.63 apiece in mid-day trading. In its second quarterly earnings report as an independent company, the Maplewood, Minnesota–based 3M Health Care spinoff reported profits of $122 million. That equals 70¢ per […]
Baxter expects $200M hit from hurricane, decreases full-year forecast
Baxter (NYSE: BAX) today said it expects to lose out on at least $200 million worth of sales due to flooding at its North Cove manufacturing facility from Hurricane Helene. That estimate — which includes about $40 million to $50 million worth of Kidney Care sales and around $150 million to $160 million worth of […]
RFK Jr. says he wants to eliminate ‘entire departments’ at FDA under Trump
Robert F. Kennedy Jr. — who claims President-elect Donald Trump promised him “control” of the U.S. Department of Health and Human Services and agencies including the FDA, CDC and NIH — today said that there are FDA departments that “have to go.” “There are entire departments like the nutrition department at the FDA … that […]
BCI developer Precision Neuroscience raises $93M in Series C round
Precision Neuroscience recently closed a $93 million funding round, the brain–computer interface (BCI) developer said in a recent financial disclosure. New York City–based Precision Neuroscience said in the Securities and Exchange Commission filing that it hoped to raise up to $150 million in this latest round, and that 21 unidentified investors took part. The equity […]
Johnson & Johnson MedTech CIO says ‘see you later’
Johnson & Johnson (NYSE:JNJ) MedTech Global VP and Group Chief Information Officer Larry Jones is leaving the world’s second-largest medical device manufacturer. “After 35 incredible years at Johnson & Johnson, I find myself reflecting on the remarkable journey we’ve experienced together,” Jones said on LinkedIn today. “To my friends and partners throughout this journey, this […]
